Published On: Thu, Nov 1st, 2018

Israeli Diabetes Prevention Startup Sweetch Partners With US-Based WellSpan Health

Sweetch app is the first AI digital prediction, prevention and improve outcomes among people with diabetes

The Israeli startup, Sweetch, the first AI digital prediction, prevention and improve outcomes among people with diabetes is partnering with integrated health care system WellSpan Health.

At first phase, Sweetch will provide its mobile health app to WellSpan Health’s 15,000 employees, including 200 primary care and specialty physicians and advanced practice clinicians in central Pennsylvania and northern Maryland.

Sweetch’s app digitally scales monitors through Bluetooth and analyzes the user’s digital bio-markers in order to prevent the disorder. This means Sweetch’s app could recommend a five-minute walk in the middle of the day to a nearby coffee shop, or a 20-minute activity, or even short nap based on the user’s personal, environmental, and behavioral lifestyle and goals.

Sweetch optimizes the user’s goals and messages, in order to predict which of these messages will trigger action with an emphasis on long-term engagement.

“This is the tool we have been looking for to augment our wellness assessment program,” said Charles Chodroff, MD, WellSpan Health’s Senior Vice President, Population Health and Chief Clinical Officer. “This new smartphone platform will take our program to the next level, by helping to target those individuals who are at the greatest risk by giving them a super-personalized tool, which automatically adapts to each individual’s life habits.”

Dana Chanan, CEO and Co-Founder of Sweetch said: “Diabetes is one of the world’s most common and costly chronic illnesses, affecting one in 11 adults globally. AI and machine learning is a must-have for fighting this epidemic. We see a great opportunity to collaborate with a leading healthcare organization that has its mission to improve health through exceptional care for all, lifelong wellness and healthy communities.”

In a recently published clinical trial conducted by Johns Hopkins, Sweetch demonstrated clinically significant effects on weight reduction, physical activity increase, and Hemoglobin A1C reduction.

The Centers for Disease Control and Prevention (CDC) estimates 33.9% of U.S. adults aged 18 years or older have pre-diabetes. That’s 84.1 million people in the US alone.


Read more about: , , ,

Wordpress site Developed by Fixing WordPress Problems